Edition:
United States

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

22.63CNY
8 Dec 2017
Change (% chg)

¥0.27 (+1.21%)
Prev Close
¥22.36
Open
¥22.25
Day's High
¥22.74
Day's Low
¥22.15
Volume
5,496,907
Avg. Vol
6,088,012
52-wk High
¥25.15
52-wk Low
¥17.66

Latest Key Developments (Source: Significant Developments)

China Resources Double-crane Pharmaceutical to set up medical industrial investment LP with partners
Wednesday, 25 Oct 2017 02:45am EDT 

Oct 25 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::Says it plans to invest 50 million yuan to set up an medical industrial investment limited partnership worth totaling 2.5 billion yuan, with partners.  Full Article

China Resources Double-Crane Pharmaceutical's 9-month net profit up 20.5 pct y/y
Tuesday, 24 Oct 2017 06:38am EDT 

Oct 24 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says its 9-month net profit up 20.5 percent y/y at 724.9 million yuan ($109.34 million).  Full Article

China Resources Double-Crane Pharmaceutical receives GMP certificate
Wednesday, 30 Aug 2017 06:43am EDT 

Aug 30(Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says it received goods manufacture practice (GMP) certificate regarding tablet, granule and hard capsule.Says the valid period is until Aug. 20, 2022.  Full Article

China Resources Double-Crane Pharmaceutical's H1 net profit up 20.1 pct y/y
Thursday, 17 Aug 2017 06:27am EDT 

Aug 17 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says H1 net profit up 20.1 percent y/y at 520.8 million yuan ($78.04 million).  Full Article

China Resources Double-crane Pharmaceutical unit receives GMP certificate
Tuesday, 1 Aug 2017 05:19am EDT 

Aug 1 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::* Says co's unit received goods manufacture practice (GMP) certificate from Hubei Food and Drug Administration, for its large volume injection products, with valid until July 6, 2022.  Full Article

China Resources Double-Crane Pharmaceutical receives GMP certificate
Friday, 7 Jul 2017 09:53am EDT 

July 7 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> ::* Says it received goods manufacture practice (GMP) certificate from Beijing Food and Drug Administration .* Certificate issued small-volume injection and gels manufactured by the company and valid period is until May 25, 2022.  Full Article

China Resources Double-Crane Pharma's Q1 net profit up 28.75 pct y/y
Wednesday, 26 Apr 2017 04:39am EDT 

April 26 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says Q1 net profit up 28.75 percent y/y.  Full Article

China Resources Double-crane Pharma sub-subsidiary receives GMP certificate
Wednesday, 12 Apr 2017 03:21am EDT 

China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> : Says its wholly owned sub-subsidiary received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration .Certificate issued to large volume injection including polypropylene dropping bottle and infusion bag manufactured by the unit and the valid period is until April 4, 2022.  Full Article

China Resources Double-crane Pharma's unit buys Hainan-based pharma firm
Wednesday, 12 Apr 2017 01:40am EDT 

China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> :Says its unit completed acquisition of a Hainan-based pharma firm.  Full Article

China Resources Double-Crane Pharma to pay annual dividend for FY 2016
Tuesday, 14 Mar 2017 04:37am EDT 

China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> : Says it will use undistributed profits to pay a cash of 0.99 yuan(pre-tax)/10 shares to shareholders for FY 2016 .Says it will distribute 2 shares/10 shares as stock dividends.  Full Article